BAYZED HEALTH Announces Board Changes: New Executive Director and Authorized Representative Appointed

Stock News06-16

BAYZED HEALTH (02609) has announced board changes following its Annual General Meeting.

Zhao Yongkai (Mr. Zhao) did not stand for re-election as an executive director as he wishes to devote more time to other business pursuits. His tenure concluded at the close of the AGM.

Consequently, with Mr. Zhao's retirement from the board, he also ceased to serve as the company's authorized representative for the purposes of Rule 3.05 of the Listing Rules following the AGM.

The board further announced that Dr. Chen Haoyang has been appointed as the authorized representative, effective June 16, 2026.

Following approval by shareholders at the AGM, Mr. Lü Chao has been appointed as an executive director, also effective from June 16, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment